Lumida
/PGNY
⌘K
Progyny Inc

Progyny Inc

PGNY
$27.35USD+1.00%+0.27 today

MARKET CAP

2.1B

P/E (TTM)

35.5x

FWD P/E

DAY RANGE

$27 – $28

52W RANGE

$16
$33

AI Summary

Stalk
TrimMedium

PGNY is in a Stage 3 distribution phase following a decisive support failure, with medium-term bearish pressure dominating despite an intact secular uptrend. Short-term execution lacks a clear edge as price holds below declining EMAs in an oversold range. We will trim into rallies toward the broken support and medium-term resistance zone around the 9/20 EMAs.

  • Q2 2026 revenue $350.5M up 5.3% YoY; gross profit rose 13% to $89.3M
  • Maintained ~100% client retention; removed majority of retention risk early
  • Q3 guide $335–345M implies pronounced slowdown; shares fell 7–15% post-earnings
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$500.6M$786.9M$1.1B$1.2B$1.3B
YoY %+45.2%+57.2%+38.3%+7.2%+10.4%
P / Sales10.1x3.9x3.4x1.4x1.8x
EV / Sales10.1x3.9x3.5x1.4x1.9x
Gross Profit, Adj.$112.1M$167.3M$238.8M$253.4M$304.5M
YoY %+60.1%+49.2%+42.7%+6.1%+20.2%
Margin %22.4%21.3%21.9%21.7%23.6%
EV / Gross Profit45.2x18.5x16.1x6.6x8.0x
EBITDA, Adj.$33.6M$24.9M$64.5M$70.6M$90.2M
YoY %+228.1%-25.9%+158.5%+9.6%+27.7%
Margin %6.7%3.2%5.9%6.1%7.0%
EV / EBITDA150.6x124.4x59.8x23.6x26.8x
EBIT$32.3M$23.3M$62.2M$67.5M$85.3M
YoY %+287.4%-27.8%+166.4%+8.5%+26.4%
Margin %6.5%3.0%5.7%5.8%6.6%
EV / EBIT156.7x133.0x61.9x24.7x28.4x
Net Income$65.8M$30.4M$62.0M$54.3M$58.5M
YoY %+41.6%-53.8%+104.4%-12.4%+7.7%
Net Margin13.1%3.9%5.7%4.7%4.5%
EPS (GAAP)$0.66$0.30$0.62$0.57$0.65
YoY %+40.4%-54.5%+106.7%-8.1%+14.0%